Clinical Trials for Hookipa Biotech

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Hookipa Biotech

Clinical Trials (2)

NCT06430905
Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART
PHASE1Active, not recruiting
30 participants
Started: Jul 1, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor5 locations
NCT06373380
A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
EARLY_PHASE1Recruiting
10 participants
Started: Apr 15, 2024 · Completed: Apr 30, 2027
1 condition3 sponsors7 locations